The identification of 5α-reductase-2 and 17β-hydroxysteroid dehydrogenase-3 gene defects in male pseudohermaphrodites from a Turkish kindred

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 2, 1998, Pages 560-569

  Can, Selcuk ^a   Zhu, Yuan Shan ^a   Cai, Li Qun ^a   Ling, Qi ^a   Katz, Melissa D ^a   Akgun, Suat ^b   Shackleton, Cedric H L ^c   Imperato Mcginley, Julianne ^a,d  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^d WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; AMINO ACID; ANDROGEN; ANDROSTANOLONE; ANDROSTERONE; DNA; ETIOCHOLANOLONE; ISOENZYME; MESSENGER RNA; STEROID 5ALPHA REDUCTASE; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE; TETRAHYDROCORTISOL;

ARTICLE; CAPILLARY GAS CHROMATOGRAPHY; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVITY; EXON; GENE; GENE MUTATION; HUMAN; INTRON; MALE; PAPER CHROMATOGRAPHY; PEDIGREE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOHERMAPHRODITISM; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; TURKEY (REPUBLIC);

17-HYDROXYSTEROID DEHYDROGENASES; AMINO ACID SEQUENCE; ANDROGENS; BASE SEQUENCE; CONSANGUINITY; DNA; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PEDIGREE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PSEUDOHERMAPHRODITISM; TESTOSTERONE 5-ALPHA-REDUCTASE; TURKEY;

EID: 0031732755     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.2.560     Document Type: Article

References (31)

1. Imperato-McGinley J, Peterson RE. 1976 Male pseudohermaphroditism: complexities of male sexual development. Am J Med. 61:251-272.
2. Imperato-McGinley J. 1996 Male pseudohermaphroditism. In: Adashi EY, Rock JA, Rosenwaks Z, eds. Reproductive endocrinology, surgery, and technology. Philadephia: Lippincott-Raven; 936-955.
3. Imperato-McGinley J, Akgun S, Ertel NH, Sayli B, Shackleton CHL. 1987 The coexistence of male pseudohermaphrodites with 17-ketosteroid reductase deficiency and 5α-reductase deficiency within a Turkish kindred. Clin Endocrinol (Oxf). 27:135-143.
4. Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE. 1974 Steroid 5α-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science. 186:1213-1216.
5. Akgun S, Ertel N, Imperato-McGinley J, Sayli B, Shackleton CHL. 1986 Familial male pseudohermaphroditism in a Turkish village due to 5α-reductase deficiency. Am J Med. 81:267-274.
6. Imperato-McGinley J, Peterson RE, Stoller R, Goodwin WE. 1979 Male pseudohermaphroditism secondary to 17β-hydroxysteroid dehydrogenase deficiency: gender role change with puberty. J Clin Endocrinol Metab. 49:391-395.
7. Peterson RE, Imperato-McGinley J, Gautier T, Sturla E. 1977 Male pseudohermaphroditism due to steroid 5α-reductase deficiency. Am J Med. 62:170-191.
8. Shackleton CHL. 1993 Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research. J Steroid Biochem. 45:127-140.
9. Peterson RE, Imperato-McGinley J, Gautier T, Shackleton CHL. 1985 Urinary steroid metabolites in subjects with male pseudohermaphroditism due to 5α-reductase deficiency. Clin Endocrinol (Oxf). 23:43-53.
10. Labrie F, Sugimoto Y, Luu-The V, et al. 1992 Structure of human type II 5α-reductase gene. Endocrinology. 131:1571-1573.
11. Cai L-Q, Zhu Y-S, Katz MD, et al. 1996 5α-Reductase-2 gene mutation in the Dominican Republic. J Clin Endocrinol Metab. 81:1730-1735.
12. Luu-The V, Sugimoto Y, Puy L, et al. 1994 Characterization, expression, and immunohistochemical localization of 5α-reductase in human skin. J Invest Dermatol. 102:221-226.
13. Zhu YS, Yen PM, Chin WW, Pfaff DW. 1996 Estrogen and thyroid hormone interaction on regulation of gene expression. Proc Natl Acad Sci USA. 93:12587-12592.
14. Normington K, Russell DW. 1992 Tissue distribution and kinetic characteristics of rat steroid 5 alpha-reductase isozymes. Evidence for distinct physiological functions. J Biol Chem. 267:19548-19554.
15. Sugimoto Y, Lopez-Solache I, Labrie F, Luu-The V. 1995 Cations inhibit specifically type I 5 alpha-reductase found in human skin. J Invest Dermatol. 104:775-778.
16. Imperato-McGinley J, Peterson RE, Gautier T, Sturla E. 1979 Male pseudohermaphroditism secondary to 5α-reductase deficiency: a model for the role of androgens in both the development of the male phenotype and the evolution of a male gender identity. J Steroid Biochem Mol Biol. 11:637-645.
17. Imperato-McGinley J, Gautier T. 1986 Inherited 5α-reductase deficiency in man. Trends Genet. 2:130-133.
18. Imperato-McGinley J, Peterson RE, Gautier T, Shackleton CHL, Arthur A. 1985 Decreased urinary C19 and C21 steroid 5α-metabolites in parents of male pseudohermaphrodites with 5α-reductase deficiency: detection of carriers. J Clin Endocrinol Metab. 60:553-558.
19. Geissler WM, Davis DL, Wu L, et al. 1994 Male pseudohermaphroditism caused by mutations of testicular 17beta-hydroxysteroid dehydrogenase 3 [see comments]. Nat Genet. 7:34-39.
20. Andersson S, Geissler WM, Wu L, et al. 1996 Molecular genetics and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 deficiency. J Clin Endocrinol Metab. 81:130-136.
21. Wigley WC, Prihoda JS, Mowszowicz I, et al. 1994 Natural mutagenesis study of the human steroid 5α-reductase 2 isozyme. Biochemistry. 33:1265-1270.
22. Embury SH, Steinberg MH. 1994 Genetic modulators of disease. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds. Sickle cell disease: basic principles and clinical practice. New York: Raven Press; 279-294.
23. Andersson S, Moghrabi N. 1997 Physiology and molecular genetics of 17β-hydroxysteroid dehydrogenases. Steroids. 62:143-147.
24. Labrie F, Luu-The V, Lin SX, et al. 1997 The key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology. Steroids. 62:148-158.
25. Katz MD, Cai L-Q, Zhu Y-S, et al. 1995 The biochemical and phenotypic characterization of females homozygous for 5α-reductase-2 deficiency. J Clin Endocrinol Metab. 80:3160-3167.
26. Zhang Y, Word RA, Fesmire S, Carr BR, Rainey WE. 1996 Human ovarian expression of 17β-hydroxysteroid dehydrogenase types 1, 2, and 3. J Clin Endocrinol Metab. 81:3594-3598.
27. Wilson JD, Griffin JE, Russell DW. 1993 Steroid 5α-reductase 2 deficiency. Endocr Rev. 14:577-593.
28. Thigpen AE, Davis DL, Milatovich A, et al. 1992 The molecular genetics of steroid 5α-reductase 2 deficiency. J Clin Invest. 90:799-809.
29. Hochberg Z, Chayen R, Reiss N, et al. 1996 Clinical, biochemical and genetic findings in a large pedigree of male and female patients with 5α-reductase 2 deficiency. J Clin Endocrinol Metab. 81:2821-2827.
30. Boudon C, Lobaccaro JM, Lumbroso S, et al. 1995 A new deletion of the 5 alpha-reductase type 2 gene in a Turkish family with 5α-reductase deficiency. Clin Endocrinol (Oxf). 43:183-188.
31. Hiort O, Sinnecker GH, Willenbring H, Lehners A, Zollner A, Strove D. 1996 Nonisotopic single strand conformation analysis of the 5α-reductase type 2 gene for the diagnosis of 5α-reductase deficiency. J Clin Endocrinol Metab. 81:3415-3418.